Skip to main content
Binex Co., Ltd. logo

Binex Co., Ltd. — Investor Relations & Filings

Ticker · 053030 ISIN · KR7053030003 KO Manufacturing
Filings indexed 223 across all filing types
Latest filing 2021-10-06 Capital/Financing Update
Country KR South Korea
Listing KO 053030

About Binex Co., Ltd.

http://www.binex.co.kr/

Binex Co., Ltd. is a biopharmaceutical company engaged in two main sectors: synthetic pharmaceuticals and biologics contract services. The pharmaceutical division manufactures and distributes a portfolio of products, including gastrointestinal tract regulators, antispasmodics, and anti-cancer drugs. As a Contract Development and Manufacturing Organization (CDMO), the company provides comprehensive services for biologics, specializing in cell line development, process development, and analytical method development. Its quality management systems are recognized by major international regulatory authorities such as the FDA, EMA, and PMDA, establishing it as a key partner in biopharmaceutical development and manufacturing.

Recent filings

Filing Released Lang Actions
교환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the exchange price for convertible bonds (exchangeable bonds) due to a decline in the market price of the underlying stock. This type of disclosure, which details changes to capital structure instruments like exchangeable bonds, falls under the 'Capital/Financing Update' category.
2021-10-06 Korean
자기주식취득결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on the Results of Treasury Stock Acquisition' (자기주식취득결과보고서) filed with the Financial Supervisory Service (금융감독원) in South Korea. It details the specific dates, quantities, and prices of shares repurchased by the company (Binex Co., Ltd.) during a specified period. This falls directly under the category of 'Transaction in Own Shares' (POS), which covers share buybacks.
2021-09-03 Korean
주요사항보고서(자기주식취득결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Binex Co., Ltd. regarding a 'Decision to Acquire Treasury Shares' (자기주식 취득 결정). This is a regulatory filing in South Korea where companies must disclose share buyback plans to the Korea Exchange. Since the document details the company's decision to buy back its own shares, it falls under the 'Transaction in Own Shares' category.
2021-08-23 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company Binex Co., Ltd. (주)바이넥스, covering the period from January 1, 2021, to June 30, 2021. It contains comprehensive financial and operational information, including company history, business overview, capital structure, and management details. As it is a formal, comprehensive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2021
2021-08-13 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically a '정정신고' (Amendment Report). It details changes to stock option exercise conditions, such as expiration dates and exercise prices, for the company Binex. This type of filing, which relates to capital structure and equity-based compensation adjustments, falls under the category of regulatory filings for corporate actions that do not fit into specific categories like M&A or dividends.
2021-08-04 Korean
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from the Korean Exchange (KRX) regarding the adjustment of the conversion price for convertible bonds (CB) due to a decline in the market price of the underlying stock. This type of disclosure, which details changes to capital structure instruments like convertible bonds, falls under the 'Capital/Financing Update' category as it directly relates to the company's financing activities and capital structure adjustments.
2021-07-06 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.